EUVIMEDEUVIMED entdecken
Crossref

Integrated network pharmacology and metabolomics to reveal the mechanism of Liangxuetuihuang formula for the treatment of intrahepatic cholestasis

Ping Lan, Chengdou Xie, Qianyu Liu, Yulan Wang, Cuihua Jiang, Jianming Ju, Siqing Chen

Biochemical and Biophysical Research Communications · 2025

DOI: 10.1016/j.bbrc.2025.152160 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemical and Biophysical Research Communications, 2025. Verfasst von Ping Lan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, People's Republic of China; Nanjing University of Chinese Medicine, Nanjing, …. Hauptthemen laut MEDLINE: Drugs, Chinese Herbal, Metabolomics, Network Pharmacology, Cholestasis, Intrahepatic. Die Arbeit nennt 72 Literaturangaben. Gefördert von: Jiangsu Provincial Health Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

To investigate and validate the mechanism of LXTHF in the treatment of IHC through network pharmacology, molecular docking technology, and animal experiments. The overall methodology included the identification of the major active ingredients of LXTHF using the ultra-performance liquid chromatography (UPLC) technique. Subsequently, network pharmacology was utilized to analyze and predict the interaction between the corresponding targets of LXTHF and IHC. Furthermore, an ANIT-induced rat model was established, and the serum and liver tissues were collected to assess the hepatoprotective effects of LXTHF, and a serum untargeted metabolomics test was performed. Finally, the precision of the results was verified at the molecular level through molecular docking, immunohistochemistry, and RT-qPCR. There were 162 active ingredients and 213 targets associated with LXTHF-IHC that were detected. The animal experiments have shown that LXTHF reversed the levels of liver function indexes in the ANIT group, which markedly performed anti-inflammatory, hepatoprotective, and enzyme-lowering effects. Combining the results of network pharmacology and metabolomics, we found that LXTHF could scavenge free radicals, suppress oxidative stress, and regulate the levels of bile acid in the serum by participating in the methionine cycle. Our results preliminarily suggested that LXTHF has a favorable anticholestatic effect in the ANIT-induced rat model, and the methionine and cysteine metabolic pathway plays an important role in this process.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drugs, Chinese HerbalMetabolomicsNetwork PharmacologyCholestasis, IntrahepaticAnimalsMaleRatsRats, Sprague-DawleyLiverMolecular Docking SimulationDisease Models, Animal

Stichwörter der Autor:innen

Liangxuetuihuang formulaintrahepatic cholestasismethionine and cysteine metabolism

Substanzen

Drugs, Chinese Herbal

Autor:innen und Institutionen

  • Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, People's Republic of China; Nanjing University of Chinese Medicine, Nanjing, People's Republic of China.
  • Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, People's Republic of China.
  • Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing, People's Republic of China; Nanjing University of Chinese Medicine, Nanjing, People's Republic of China. Electronic address: jiangshan…
  • Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing, People's Republic of China; Nanjing University of Chinese Medicine, Nanjing, People's Republic of China. Electronic address: jjm405@si…
  • Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, People's Republic of China; Nanjing University of Chinese Medicine, Nanjing, People's Republic of China. Electronic address: yfy0048@njucm.edu.cn.

Förderung

  • Jiangsu Provincial Health Commission

Zitieren

APA

Lan, P., Xie, C., Liu, Q., Wang, Y., Jiang, C., Ju, J., & Chen, S. (2025). Integrated network pharmacology and metabolomics to reveal the mechanism of Liangxuetuihuang formula for the treatment of intrahepatic cholestasis. Biochemical and Biophysical Research Communications. https://doi.org/10.1016/j.bbrc.2025.152160

Vancouver

Lan P, Xie C, Liu Q, Wang Y, Jiang C, Ju J, et al. Integrated network pharmacology and metabolomics to reveal the mechanism of Liangxuetuihuang formula for the treatment of intrahepatic cholestasis. Biochemical and Biophysical Research Communications. 2025. doi:10.1016/j.bbrc.2025.152160

BibTeX
@article{Lan2025,
  author = {Lan, Ping and Xie, Chengdou and Liu, Qianyu and Wang, Yulan and Jiang, Cuihua and Ju, Jianming and Chen, Siqing},
  title = {Integrated network pharmacology and metabolomics to reveal the mechanism of Liangxuetuihuang formula for the treatment of intrahepatic cholestasis},
  journal = {Biochemical and Biophysical Research Communications},
  year = {2025},
  doi = {10.1016/j.bbrc.2025.152160}
}
Kostenlos starten →